Short Summary
Syngenta Crop Protection AG's petition to invalidate Inflexion Point Technologies' patent was denied by the PTAB. The Board found insufficient evidence of anticipation or obviousness across multiple grounds, rejecting all challenges including enablement.
Detailed Summary
The Patent Trial and Appeal Board (PTAB) issued a denial decision in this case, finding that Petitioner Syngenta Crop Protection AG failed to establish a likelihood of unpatentability for any challenged claim of U.S. Patent No. 12102027. The challenges spanned anticipation (102), obviousness (103), and enablement (112). Key arguments centered on whether prior art disclosed the individual application of seed-applied substances, a limitation central to Claim 1. The Board ultimately found that the evidence did not meet the required threshold for institution, particularly regarding the scope of 'seed-applied substance' and the routine nature of the claimed method.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Syngenta Crop Protection AG vs Inflexion Point Technologies, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Rode Microphones, LLC et al.vsZaxcom, Inc.
RØDE Microphones and Freedman Electronics have filed an IPR petition seeking cancellation of 11 claims of Zaxcom’s ’207 patent, arguing obviousness over four prior‑art references and invoking collateral estoppel from earlier PTAB decisions.
Empower Clinic Services, LLC. (d/b/a Empower Pharmacy)vsEli Lilly & Co.
Eli Lilly successfully defended its tirzepatide patent against Empower Clinic Services’ request for Director Review. The PTAB affirmed the discretionary denial of institution, citing Lilly’s strong settled expectations and lack of material examination error.
Samsara Inc.vsMotive Technologies, Inc.
The PTAB granted institution of IPR for Samsara Inc. against Motive Technologies, Inc., challenging 7 claims in patent 11875580. The Board found a reasonable likelihood that the petitioner would prevail on claim 1 based on prior art combinations.
UNION ELECTRIC COMPANY et al.vsMES, Inc.
The Board notified the parties that Director Review requests for two IPRs have been received and set a five‑day deadline for the patent owner to file a limited response, prohibiting new evidence.
Intel Corporation et al.vsAdvanced Cluster Systems, Inc.
AMD and Advanced Cluster Systems have settled their IPR dispute over U.S. Patent 12,021,679 and jointly moved to keep the settlement agreement confidential under statutory provisions.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.